Evidence map›Paper›PMID 30013227›Full record

ArticleScientific reports2018

Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer.

Andreas E Albers, Xu Qian, Andreas M Kaufmann, Daphne Mytilineos, Robert L Ferris, Thomas K Hoffmann, Albert B DeLeo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Clinical and Immunological Effects of p53-Targeting Vaccines.Frontiers in cell and developmental biology · 2021
    Review
  6. The p53 Saga: Early Steps in the Development of Tumor Immunotherapy.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Review
  7. A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Andreas E AlbersDepartment of Otorhinolaryngology, Head and Neck Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany. andreas.albers@charite.de.ORCID 0000-0001-5614-9873
Xu QianDepartment of Otorhinolaryngology, Head and Neck Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.
Andreas M KaufmannClinic for Gynecology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.
Daphne MytilineosDepartment of Otolaryngology, Head and Neck Surgery, University of Ulm, Ulm, Germany.
Robert L FerrisDepartment of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Thomas K HoffmannDepartment of Otolaryngology, Head and Neck Surgery, University of Ulm, Ulm, Germany.
Albert B DeLeoUniversity of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Humboldt-Universität zu Berlin · DEUniversität Ulm · DEUniversity of Pittsburgh · USUniversity of Pittsburgh Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD8

Indexed as

AgedAged, 80 and overAntigens, NeoplasmEpitopes, T-LymphocyteFemaleHead and Neck NeoplasmsHLA-A2 AntigenHumansMaleMiddle AgedPeptide FragmentsSquamous Cell Carcinoma of Head and NeckT-Lymphocytes, CytotoxicTumor Suppressor Protein p53Antigens, NeoplasmEpitopes, T-LymphocyteHLA-A2 AntigenPeptide FragmentsTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID30013227
PMCPMC6048165
OpenAlexW2852455287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.